Izabela Muszalska-Kolos

Dr. Izabela Muszalska-Kolos

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MZMarianna Zając
Marianna Zając
IMIzabela Muszalska-Kolos
Izabela Muszalska-Kolos
ASAgnieszka Sobczak
Agnieszka Sobczak
ADAdrianna Dadej
Adrianna Dadej
STSzymon Tomczak
Szymon Tomczak
Anna JelińskaAnna Jelińska
Anna Jelińska

12 November 2024 in Molecules
Verified
Journal Article
Open access
PDF file
JKJoanna Kuźmińska
Joanna Kuźmińska
PSPiotr Szyk
Piotr Szyk
DMDariusz Mlynarczyk
Dariusz Mlynarczyk
Paweł BakunPaweł Bakun
Paweł Bakun
IMIzabela Muszalska-Kolos
Izabela Muszalska-Kolos
Anna JelińskaAnna Jelińska
Anna Jelińska
Curcumin, a naturally occurring compound found in the rhizome of Curcuma plants, particularly in turmeric (Curcuma longa L.), exhibits a broad range of biological activities, including anti-inflammatory, antioxidant, and anticancer properties. Curcumin has demonstrated effectiveness in inhibiting tumor growth, arousing interest for its potential in treating various cancers, such as breast, lung, prostate, and brain cancers. However, the clinical application of curcumin is limited due to its low chemical stability, poor water solubility, and low bioavailability. In response to these challenges, structural modifications of curcumin have been explored to improve its pharmacological properties, including enhanced anticancer selectivity index and bioavailability. This review highlights promising chemical modifications of curcumin that could lead to the development of more effective anticancer therapies. By functionalizing the parent curcumin molecule, researchers aim to create more stable and bioavailable compounds with enhanced therapeutic potential, making curcumin derivatives promising candidates for medical applications.

5 July 2020 in Cancers
Verified
Journal Article
Open access
PDF file
LPLudwika Piwowarczyk
Ludwika Piwowarczyk
Maciej StawnyMaciej Stawny
Maciej Stawny
DMDariusz Mlynarczyk
Dariusz Mlynarczyk
IMIzabela Muszalska-Kolos
Izabela Muszalska-Kolos
TGTomasz Gośliński
Tomasz Gośliński
Anna JelińskaAnna Jelińska
Anna Jelińska
The incidence of bladder cancer (BC) is increasing, and although current therapeutic approaches are effective in many cases, recurrence of BC is common. Therefore, it seems necessary to search not only for novel therapeutic approaches, but also for new therapeutic agents. Natural polyphenols, such as curcumin (CUR) and epigallocatechin gallate (EGCG), possess remarkable antitumor activity. Their biochemical mechanisms of action include regulation of signaling pathways, modeling of proteins involved in apoptosis and cell cycle inhibition, angiogenesis, and the proliferation, migration and adhesion of tumor cells. Both compounds also present antioxidant, anti-inflammatory, antibacterial and antiviral properties. CUR has been considered a promising candidate for the treatment of cystic fibrosis, Alzheimer’s disease or malaria, whereas EGCG can play a supportive role in the treatment of obesity, metabolic and neurodegenerative diseases. The review summarizes the latest research on the role of CUR and EGCG in the treatment of BC. In particular, the effects of CUR and EGCG, and their prospects for use in BC therapy, their inhibition of cancer development and their prevention of multidrug resistance, are described. The literature’s data indicate the possibility of achieving the effect of synergism of both polyphenols in BC therapy, which has been observed so far in the treatment of ovarian, breast and prostate cancer.

1 March 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MLMonika A. Lesniewska-Kowiel
Monika A. Lesniewska-Kowiel
IMIzabela Muszalska-Kolos
Izabela Muszalska-Kolos

22 December 2019 in Molecules
Verified
Journal Article
Open access
PDF file
KWKatarzyna B. Wróblewska
Katarzyna B. Wróblewska
SPSzymon Plewa
Szymon Plewa
PDPaweł Dereziński
Paweł Dereziński
IMIzabela Muszalska-Kolos
Izabela Muszalska-Kolos
Choline salicylate (CS) as a derivative of acetylsalicylic acid is commonly used in different drug forms. In medicine, it is applied topically to inflammation of the oral cavity mucosa and in laryngology. However, this substance in the form of an ionic liquid has not been investigated enough. There are no literature studies on stability tests constituting a stage of pre-formulation research. HPLC (Nucleosil C18, 4.6 × 150 mm, 5 μm; methanol-water-acetic acid 60:40:1, 230 nm or 270 nm) and UV (276 nm) methods for the determination of CS in 2% (g/mL) aqueous solutions were developed. Under stress conditions, CS susceptibility to hydrolytic degradation in aqueous medium, hydrochloric acid, sodium hydroxide, and hydrogen peroxide, and the effect of light on the stability of CS solutions were studied with HPLC analysis. The degradation degree of CS and the purity of the solutions were also tested. Choline salicylate has been qualified as practically stable in neutral and acid media, stable in an alkaline medium, very stable in an oxidizing environment, and photolabile in solution. The HPLC-MS/MS method was used to identify 2,3- and 2,5-dihydroxybenzoic acids as degradation products of CS under the tested conditions.

7 March 2015 in Journal of Analytical Chemistry
Verified
Journal Article
Closed access
PDF file
IMIzabela Muszalska-Kolos
Izabela Muszalska-Kolos
ASA. Sobczak
A. Sobczak
IKI. Kiaszewicz
I. Kiaszewicz
KRK. Rabiega
K. Rabiega
MLM. A. Lesniewska
M. A. Lesniewska
Anna JelińskaAnna Jelińska
Anna Jelińska
A selective ultraviolet and visible spectrophotometric method (UV-Vis) for the determination of memantine (MM) and rimantadine (RM) hydrochlorides after derivatization with 1,2-naphtoquinone-4-sulfonic acid sodium salt (NQS) and extraction with dichloromethane was developed and optimized. The reaction of the NQS (0.7%, w/v solution) with memantine was carried out for 40 min in a buffer medium of NaOH/KCl (pH 12.0) at 80°C. A mixture of NQS (0.2%) and rimantadine was heated for 20 min at 50°C, in a medium of NaOH/KCl (pH 12.0). The linearity of the determinations of MM (0.05–0.60 mg/mL) and RM (0.05–0.30 mg/mL) was evaluated. LOD (28 mg/mL for MM, 11 mg/mL for RM) and LOQ (84 mg/mL for MM, 32 mg/mL for RM) values and parameters of precision and accuracy were determined. The UV-Vis method for the determination of rimantadine hydrochloride tablets was validated (selectivity, linearity, precision, accuracy).